| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Prophages | 3 | 2019 | 11 | 1.78 | Why? |
| beta-Lactamases | 5 | 2019 | 759 | 1.27 | Why? |
| Liver | 20 | 2018 | 4007 | 1.11 | Why? |
| Klebsiella pneumoniae | 3 | 2018 | 658 | 1.08 | Why? |
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 1014 | 1.03 | Why? |
| Gadolinium DTPA | 8 | 2019 | 45 | 0.93 | Why? |
| Liver Neoplasms | 12 | 2021 | 1666 | 0.89 | Why? |
| Isoflurane | 2 | 2017 | 38 | 0.84 | Why? |
| Cholangiocarcinoma | 3 | 2018 | 186 | 0.83 | Why? |
| Carcinoma, Hepatocellular | 9 | 2021 | 1222 | 0.77 | Why? |
| Chromosome Disorders | 1 | 2018 | 24 | 0.76 | Why? |
| Aneuploidy | 1 | 2018 | 27 | 0.75 | Why? |
| Low Density Lipoprotein Receptor-Related Protein-1 | 2 | 2017 | 17 | 0.74 | Why? |
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2018 | 291 | 0.74 | Why? |
| Pyrophosphatases | 1 | 2018 | 39 | 0.74 | Why? |
| Food Irradiation | 1 | 2017 | 2 | 0.74 | Why? |
| Education, Special | 1 | 2018 | 28 | 0.74 | Why? |
| Mushroom Poisoning | 1 | 2018 | 10 | 0.74 | Why? |
| Lymphocyte Antigen 96 | 1 | 2017 | 16 | 0.73 | Why? |
| Phaeophyta | 1 | 2018 | 46 | 0.72 | Why? |
| Ribonuclease, Pancreatic | 1 | 2017 | 24 | 0.71 | Why? |
| Red Meat | 1 | 2017 | 39 | 0.71 | Why? |
| Marfan Syndrome | 1 | 2017 | 27 | 0.71 | Why? |
| Enzymes, Immobilized | 1 | 2017 | 30 | 0.70 | Why? |
| Electrons | 1 | 2017 | 53 | 0.70 | Why? |
| Ischemic Postconditioning | 1 | 2017 | 13 | 0.69 | Why? |
| Erythrocyte Indices | 1 | 2019 | 207 | 0.69 | Why? |
| Reading | 1 | 2018 | 80 | 0.69 | Why? |
| Bile Duct Neoplasms | 2 | 2018 | 172 | 0.69 | Why? |
| NADPH Oxidase 2 | 1 | 2017 | 58 | 0.69 | Why? |
| Nanotubes | 1 | 2018 | 72 | 0.68 | Why? |
| Imipenem | 1 | 2017 | 57 | 0.68 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 92 | 0.67 | Why? |
| Forearm Injuries | 1 | 2016 | 5 | 0.67 | Why? |
| Neoplastic Stem Cells | 1 | 2018 | 120 | 0.66 | Why? |
| Joint Instability | 1 | 2016 | 20 | 0.65 | Why? |
| Fetal Growth Retardation | 1 | 2019 | 217 | 0.65 | Why? |
| Hyperthermia, Induced | 1 | 2018 | 106 | 0.64 | Why? |
| Ultrasonography, Prenatal | 2 | 2018 | 471 | 0.64 | Why? |
| Anti-Bacterial Agents | 5 | 2019 | 10083 | 0.63 | Why? |
| Autism Spectrum Disorder | 3 | 2019 | 587 | 0.63 | Why? |
| Matrix Metalloproteinases | 1 | 2017 | 131 | 0.63 | Why? |
| DNA Methylation | 2 | 2018 | 688 | 0.62 | Why? |
| beta-Lactam Resistance | 1 | 2017 | 150 | 0.61 | Why? |
| Bacterial Proteins | 4 | 2019 | 1318 | 0.61 | Why? |
| ErbB Receptors | 1 | 2018 | 320 | 0.60 | Why? |
| Gene Expression Regulation, Enzymologic | 2 | 2018 | 436 | 0.60 | Why? |
| Genetic Testing | 2 | 2018 | 395 | 0.60 | Why? |
| Prenatal Diagnosis | 1 | 2018 | 345 | 0.59 | Why? |
| Comprehension | 1 | 2018 | 259 | 0.58 | Why? |
| Photosensitizing Agents | 1 | 2018 | 279 | 0.58 | Why? |
| Carbapenems | 1 | 2018 | 343 | 0.58 | Why? |
| X-Rays | 1 | 2017 | 492 | 0.58 | Why? |
| Contrast Media | 8 | 2019 | 1011 | 0.56 | Why? |
| Aortic Aneurysm, Thoracic | 1 | 2017 | 161 | 0.56 | Why? |
| Pregnancy Complications, Cardiovascular | 1 | 2017 | 231 | 0.55 | Why? |
| Endocytosis | 1 | 2017 | 451 | 0.55 | Why? |
| Toll-Like Receptor 4 | 1 | 2017 | 390 | 0.55 | Why? |
| Liver Failure, Acute | 1 | 2018 | 279 | 0.55 | Why? |
| Klebsiella Infections | 2 | 2018 | 466 | 0.54 | Why? |
| Magnetic Resonance Imaging | 12 | 2021 | 6551 | 0.53 | Why? |
| Tissue Plasminogen Activator | 2 | 2017 | 778 | 0.53 | Why? |
| Gold | 1 | 2018 | 592 | 0.51 | Why? |
| Nephrectomy | 1 | 2017 | 406 | 0.50 | Why? |
| Gene Regulatory Networks | 1 | 2018 | 820 | 0.50 | Why? |
| Oocytes | 3 | 2018 | 86 | 0.49 | Why? |
| Photochemotherapy | 1 | 2018 | 297 | 0.49 | Why? |
| Aneurysm, Dissecting | 1 | 2017 | 303 | 0.48 | Why? |
| Gram-Negative Bacteria | 1 | 2017 | 473 | 0.48 | Why? |
| Living Donors | 5 | 2018 | 652 | 0.48 | Why? |
| Glycoproteins | 1 | 2017 | 615 | 0.47 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2017 | 398 | 0.47 | Why? |
| Enzyme Activation | 3 | 2017 | 425 | 0.46 | Why? |
| DNA | 1 | 2017 | 778 | 0.45 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.45 | Why? |
| Plasmids | 3 | 2019 | 840 | 0.44 | Why? |
| Liver Transplantation | 8 | 2018 | 2864 | 0.42 | Why? |
| Ultrasonography, Doppler | 3 | 2018 | 406 | 0.42 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.42 | Why? |
| Catheter Ablation | 3 | 2021 | 438 | 0.40 | Why? |
| Nanostructures | 1 | 2017 | 700 | 0.40 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.39 | Why? |
| Cost-Benefit Analysis | 2 | 2018 | 2259 | 0.38 | Why? |
| Laparoscopy | 2 | 2018 | 1532 | 0.38 | Why? |
| Robotic Surgical Procedures | 1 | 2017 | 787 | 0.38 | Why? |
| Macrophages | 2 | 2018 | 2784 | 0.38 | Why? |
| Postoperative Complications | 5 | 2018 | 5861 | 0.37 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.37 | Why? |
| Kidney Neoplasms | 1 | 2017 | 832 | 0.37 | Why? |
| Hepatic Artery | 2 | 2018 | 31 | 0.37 | Why? |
| Molecular Targeted Therapy | 1 | 2018 | 1579 | 0.36 | Why? |
| Myotonic Dystrophy | 1 | 2008 | 51 | 0.36 | Why? |
| Palmitic Acid | 2 | 2017 | 28 | 0.36 | Why? |
| Image Enhancement | 3 | 2019 | 177 | 0.35 | Why? |
| Biliary Tract | 2 | 2017 | 21 | 0.35 | Why? |
| Cholangiopancreatography, Magnetic Resonance | 2 | 2017 | 40 | 0.35 | Why? |
| Republic of Korea | 12 | 2022 | 5858 | 0.34 | Why? |
| Chitosan | 3 | 2018 | 196 | 0.34 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.31 | Why? |
| Doxorubicin | 2 | 2018 | 313 | 0.31 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.30 | Why? |
| Behavior Therapy | 2 | 2019 | 235 | 0.30 | Why? |
| Carrier State | 1 | 2017 | 2100 | 0.29 | Why? |
| Liver Cirrhosis | 6 | 2018 | 1810 | 0.29 | Why? |
| Elasticity Imaging Techniques | 2 | 2017 | 194 | 0.28 | Why? |
| Korea | 2 | 2017 | 89 | 0.27 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.26 | Why? |
| Fatty Liver | 3 | 2018 | 299 | 0.25 | Why? |
| Image Interpretation, Computer-Assisted | 3 | 2018 | 665 | 0.25 | Why? |
| Breast Neoplasms | 2 | 2018 | 3633 | 0.25 | Why? |
| Subtraction Technique | 2 | 2019 | 11 | 0.25 | Why? |
| Cattle | 2 | 2017 | 1336 | 0.25 | Why? |
| Mass Screening | 2 | 2020 | 8005 | 0.25 | Why? |
| Hydrogels | 3 | 2019 | 173 | 0.24 | Why? |
| Mice | 13 | 2019 | 21357 | 0.24 | Why? |
| Cell Hypoxia | 3 | 2017 | 141 | 0.24 | Why? |
| Salvage Therapy | 2 | 2016 | 417 | 0.24 | Why? |
| HCT116 Cells | 2 | 2018 | 83 | 0.23 | Why? |
| Animals | 26 | 2021 | 78931 | 0.23 | Why? |
| Light | 3 | 2018 | 306 | 0.23 | Why? |
| Inflammation | 4 | 2018 | 13255 | 0.23 | Why? |
| Inflammasomes | 2 | 2018 | 710 | 0.23 | Why? |
| Gene Expression Profiling | 5 | 2021 | 3788 | 0.22 | Why? |
| Hepatic Stellate Cells | 2 | 2018 | 35 | 0.22 | Why? |
| MCF-7 Cells | 2 | 2018 | 199 | 0.22 | Why? |
| Xenograft Model Antitumor Assays | 2 | 2018 | 274 | 0.21 | Why? |
| Microbial Sensitivity Tests | 3 | 2018 | 2886 | 0.21 | Why? |
| Humans | 83 | 2022 | 930598 | 0.21 | Why? |
| Blastocyst | 2 | 2018 | 65 | 0.21 | Why? |
| Radiosurgery | 3 | 2018 | 249 | 0.20 | Why? |
| Diet, High-Fat | 2 | 2018 | 161 | 0.20 | Why? |
| Superior Colliculi | 1 | 2019 | 1 | 0.20 | Why? |
| Sensory Deprivation | 1 | 2019 | 6 | 0.20 | Why? |
| Proteins | 2 | 2018 | 921 | 0.20 | Why? |
| Hepatocytes | 3 | 2018 | 549 | 0.20 | Why? |
| Salmon | 1 | 2019 | 18 | 0.20 | Why? |
| Chimera | 1 | 2019 | 83 | 0.20 | Why? |
| Hypertension, Portal | 2 | 2017 | 73 | 0.20 | Why? |
| Intranuclear Space | 1 | 2018 | 2 | 0.19 | Why? |
| Adenylate Kinase | 1 | 2018 | 13 | 0.19 | Why? |
| Insulin Glargine | 1 | 2019 | 43 | 0.19 | Why? |
| Bisphosphonate-Associated Osteonecrosis of the Jaw | 1 | 2019 | 18 | 0.19 | Why? |
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 502 | 0.19 | Why? |
| CX3C Chemokine Receptor 1 | 1 | 2018 | 21 | 0.19 | Why? |
| Betamethasone | 1 | 2019 | 63 | 0.19 | Why? |
| Visual Perception | 1 | 2019 | 49 | 0.19 | Why? |
| TRPM Cation Channels | 1 | 2018 | 25 | 0.19 | Why? |
| MAP Kinase Kinase Kinase 5 | 1 | 2018 | 16 | 0.19 | Why? |
| Chitin | 1 | 2019 | 32 | 0.19 | Why? |
| Bone Morphogenetic Protein 2 | 1 | 2018 | 24 | 0.19 | Why? |
| Plasmodium ovale | 1 | 2019 | 34 | 0.19 | Why? |
| Neoplasms, Experimental | 1 | 2019 | 67 | 0.19 | Why? |
| Amanita | 1 | 2018 | 4 | 0.19 | Why? |
| Nuclear Transfer Techniques | 1 | 2018 | 6 | 0.19 | Why? |
| Solanine | 1 | 2017 | 1 | 0.19 | Why? |
| Apoptosis | 3 | 2017 | 2335 | 0.19 | Why? |
| Male | 54 | 2021 | 367725 | 0.19 | Why? |
| Diastole | 1 | 2019 | 168 | 0.18 | Why? |
| Myofibrils | 1 | 2017 | 3 | 0.18 | Why? |
| Mice, Inbred C57BL | 6 | 2019 | 5542 | 0.18 | Why? |
| Infant, Small for Gestational Age | 1 | 2019 | 151 | 0.18 | Why? |
| Adenocarcinoma, Mucinous | 1 | 2018 | 27 | 0.18 | Why? |
| Maturation-Promoting Factor | 1 | 2017 | 1 | 0.18 | Why? |
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2018 | 19 | 0.18 | Why? |
| Drug Delivery Systems | 2 | 2018 | 1365 | 0.18 | Why? |
| KCNQ1 Potassium Channel | 1 | 2018 | 10 | 0.18 | Why? |
| Tomography, X-Ray Computed | 10 | 2018 | 25144 | 0.18 | Why? |
| Carbon Tetrachloride | 1 | 2017 | 27 | 0.18 | Why? |
| Diseases in Twins | 1 | 2019 | 86 | 0.18 | Why? |
| Paclitaxel | 1 | 2019 | 124 | 0.18 | Why? |
| Transcription Factor RelA | 1 | 2018 | 122 | 0.18 | Why? |
| Teratoma | 1 | 2018 | 25 | 0.18 | Why? |
| Metabolic Clearance Rate | 1 | 2018 | 110 | 0.18 | Why? |
| ERG1 Potassium Channel | 1 | 2018 | 17 | 0.18 | Why? |
| Histone Code | 1 | 2017 | 25 | 0.18 | Why? |
| Oogenesis | 1 | 2017 | 13 | 0.18 | Why? |
| Radiographic Image Enhancement | 1 | 2018 | 89 | 0.18 | Why? |
| CD11b Antigen | 1 | 2017 | 90 | 0.18 | Why? |
| Fiducial Markers | 1 | 2017 | 8 | 0.18 | Why? |
| Osteogenesis | 1 | 2018 | 95 | 0.18 | Why? |
| Enzyme Stability | 1 | 2017 | 72 | 0.18 | Why? |
| Respiratory Distress Syndrome, Newborn | 1 | 2019 | 124 | 0.18 | Why? |
| Hepatic Veins | 1 | 2018 | 54 | 0.18 | Why? |
| Warm Ischemia | 1 | 2017 | 33 | 0.18 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.18 | Why? |
| Antibiotics, Antineoplastic | 1 | 2018 | 128 | 0.18 | Why? |
| Protein-Tyrosine Kinases | 1 | 2019 | 158 | 0.18 | Why? |
| Adenosine Diphosphate Ribose | 1 | 2018 | 126 | 0.18 | Why? |
| Fetal Mortality | 1 | 2017 | 34 | 0.18 | Why? |
| Transcriptome | 3 | 2021 | 3466 | 0.17 | Why? |
| p21-Activated Kinases | 1 | 2017 | 14 | 0.17 | Why? |
| Polydeoxyribonucleotides | 1 | 2019 | 118 | 0.17 | Why? |
| Cholangiography | 1 | 2017 | 19 | 0.17 | Why? |
| Pancreatic Ducts | 1 | 2017 | 29 | 0.17 | Why? |
| Constriction | 1 | 2017 | 44 | 0.17 | Why? |
| Syndecan-2 | 1 | 2016 | 4 | 0.17 | Why? |
| DNA, Ribosomal | 1 | 2017 | 112 | 0.17 | Why? |
| Hepatectomy | 2 | 2018 | 276 | 0.17 | Why? |
| Histone-Lysine N-Methyltransferase | 1 | 2018 | 82 | 0.17 | Why? |
| Bile Ducts, Intrahepatic | 1 | 2018 | 68 | 0.17 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2016 | 8843 | 0.17 | Why? |
| Cyclin-Dependent Kinases | 1 | 2017 | 124 | 0.17 | Why? |
| Multilocus Sequence Typing | 1 | 2018 | 264 | 0.17 | Why? |
| Radiotherapy, Intensity-Modulated | 1 | 2018 | 148 | 0.17 | Why? |
| Growth Differentiation Factor 15 | 1 | 2017 | 89 | 0.17 | Why? |
| HeLa Cells | 2 | 2018 | 1303 | 0.17 | Why? |
| Carcinoma, Papillary | 1 | 2018 | 76 | 0.17 | Why? |
| Forkhead Box Protein O3 | 1 | 2016 | 30 | 0.17 | Why? |
| Cell Survival | 3 | 2018 | 1581 | 0.17 | Why? |
| Protein Isoforms | 1 | 2018 | 347 | 0.17 | Why? |
| Fractures, Ununited | 1 | 2016 | 5 | 0.17 | Why? |
| Female | 44 | 2021 | 380317 | 0.17 | Why? |
| Cell Line, Tumor | 4 | 2019 | 3608 | 0.17 | Why? |
| RAW 264.7 Cells | 1 | 2017 | 316 | 0.17 | Why? |
| Transforming Growth Factor beta1 | 1 | 2018 | 204 | 0.16 | Why? |
| Phenylethyl Alcohol | 1 | 2017 | 74 | 0.16 | Why? |
| Fractures, Open | 1 | 2016 | 29 | 0.16 | Why? |
| Blood Proteins | 1 | 2020 | 551 | 0.16 | Why? |
| Tissue Scaffolds | 1 | 2018 | 174 | 0.16 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.16 | Why? |
| Arteries | 1 | 2019 | 283 | 0.16 | Why? |
| Bone Transplantation | 1 | 2016 | 38 | 0.16 | Why? |
| Marital Status | 1 | 2017 | 186 | 0.16 | Why? |
| Gestational Age | 2 | 2019 | 1488 | 0.16 | Why? |
| Swine | 4 | 2018 | 3352 | 0.16 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.16 | Why? |
| Precancerous Conditions | 1 | 2017 | 108 | 0.16 | Why? |
| Spermatozoa | 1 | 2019 | 244 | 0.15 | Why? |
| Astrocytes | 1 | 2018 | 298 | 0.15 | Why? |
| Preoperative Period | 1 | 2017 | 271 | 0.15 | Why? |
| Molecular Typing | 1 | 2017 | 280 | 0.15 | Why? |
| Anesthetics, Inhalation | 1 | 2017 | 82 | 0.15 | Why? |
| Virulence Factors | 1 | 2018 | 338 | 0.15 | Why? |
| Patient Outcome Assessment | 2 | 2018 | 707 | 0.15 | Why? |
| Ethanol | 2 | 2018 | 533 | 0.15 | Why? |
| Cell Differentiation | 2 | 2018 | 1338 | 0.15 | Why? |
| Plasmodium falciparum | 1 | 2019 | 337 | 0.14 | Why? |
| Propofol | 1 | 2017 | 172 | 0.14 | Why? |
| Glioblastoma | 1 | 2018 | 187 | 0.14 | Why? |
| Toll-Like Receptor 3 | 1 | 2018 | 391 | 0.14 | Why? |
| Oropharynx | 2 | 2020 | 1581 | 0.14 | Why? |
| Perinatal Death | 1 | 2018 | 372 | 0.14 | Why? |
| Choice Behavior | 1 | 2018 | 319 | 0.14 | Why? |
| Pancreas | 1 | 2018 | 398 | 0.14 | Why? |
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2017 | 237 | 0.14 | Why? |
| Fracture Fixation, Internal | 1 | 2016 | 188 | 0.14 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 372 | 0.14 | Why? |
| Fertilization in Vitro | 1 | 2018 | 330 | 0.14 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2017 | 385 | 0.14 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.13 | Why? |
| Respiratory Mechanics | 1 | 2018 | 585 | 0.13 | Why? |
| Adult | 31 | 2021 | 244371 | 0.13 | Why? |
| RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.13 | Why? |
| Pregnancy | 5 | 2019 | 23879 | 0.13 | Why? |
| Proteome | 2 | 2021 | 1812 | 0.13 | Why? |
| Sensitivity and Specificity | 9 | 2022 | 22971 | 0.13 | Why? |
| Genotype | 3 | 2018 | 4697 | 0.13 | Why? |
| Retrospective Studies | 20 | 2021 | 105322 | 0.13 | Why? |
| Antineoplastic Agents | 3 | 2019 | 3550 | 0.13 | Why? |
| Middle Aged | 32 | 2021 | 270681 | 0.13 | Why? |
| Hydrogen-Ion Concentration | 1 | 2017 | 993 | 0.13 | Why? |
| Prostatectomy | 1 | 2018 | 485 | 0.13 | Why? |
| Evolution, Molecular | 2 | 2018 | 3691 | 0.13 | Why? |
| Maternal Mortality | 1 | 2017 | 461 | 0.13 | Why? |
| Microvessels | 1 | 2018 | 490 | 0.13 | Why? |
| Prognosis | 6 | 2021 | 32490 | 0.13 | Why? |
| Calcium | 1 | 2018 | 708 | 0.13 | Why? |
| Thyroid Neoplasms | 1 | 2018 | 422 | 0.13 | Why? |
| Ovarian Neoplasms | 1 | 2019 | 465 | 0.13 | Why? |
| Neoplasms | 2 | 2021 | 17251 | 0.12 | Why? |
| Radiotherapy Planning, Computer-Assisted | 1 | 2013 | 172 | 0.12 | Why? |
| Glucosides | 1 | 2017 | 359 | 0.12 | Why? |
| Immunophenotyping | 1 | 2017 | 1290 | 0.12 | Why? |
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 451 | 0.12 | Why? |
| Delayed-Action Preparations | 3 | 2019 | 291 | 0.12 | Why? |
| Ultrasonography, Interventional | 1 | 2017 | 560 | 0.12 | Why? |
| Computational Biology | 2 | 2018 | 4514 | 0.12 | Why? |
| Brain Ischemia | 2 | 2018 | 2813 | 0.12 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.12 | Why? |
| Models, Biological | 3 | 2018 | 4907 | 0.12 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.12 | Why? |
| Robotics | 1 | 2018 | 528 | 0.12 | Why? |
| Hypnotics and Sedatives | 1 | 2017 | 624 | 0.12 | Why? |
| Brain Injuries | 1 | 2017 | 374 | 0.12 | Why? |
| A549 Cells | 1 | 2018 | 2066 | 0.11 | Why? |
| Interleukin-1beta | 1 | 2016 | 992 | 0.11 | Why? |
| Colon | 1 | 2016 | 669 | 0.11 | Why? |
| Liver Function Tests | 1 | 2018 | 1325 | 0.11 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.11 | Why? |
| Computer-Assisted Instruction | 1 | 2019 | 658 | 0.11 | Why? |
| Asia | 1 | 2018 | 2399 | 0.11 | Why? |
| Pancreatic Neoplasms | 1 | 2018 | 609 | 0.11 | Why? |
| Aged | 24 | 2021 | 215776 | 0.11 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.11 | Why? |
| Glomerular Filtration Rate | 1 | 2017 | 1262 | 0.11 | Why? |
| Exosomes | 1 | 2017 | 567 | 0.11 | Why? |
| Dose-Response Relationship, Drug | 2 | 2017 | 3776 | 0.11 | Why? |
| Treatment Outcome | 11 | 2019 | 51732 | 0.11 | Why? |
| Neoplasm Recurrence, Local | 4 | 2021 | 1063 | 0.11 | Why? |
| Young Adult | 13 | 2021 | 93724 | 0.11 | Why? |
| Muscle, Skeletal | 1 | 2017 | 915 | 0.11 | Why? |
| Autophagy | 1 | 2017 | 960 | 0.10 | Why? |
| Phosphoproteins | 2 | 2020 | 4346 | 0.10 | Why? |
| Biomarkers | 5 | 2021 | 23361 | 0.10 | Why? |
| Infant, Newborn | 4 | 2019 | 23105 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Membrane Glycoproteins | 1 | 2019 | 2273 | 0.10 | Why? |
| Blotting, Southern | 1 | 2008 | 18 | 0.10 | Why? |
| Trinucleotide Repeat Expansion | 1 | 2008 | 9 | 0.10 | Why? |
| Crystallography, X-Ray | 1 | 2017 | 2689 | 0.10 | Why? |
| Cell Line | 4 | 2018 | 12040 | 0.10 | Why? |
| Myotonin-Protein Kinase | 1 | 2008 | 16 | 0.10 | Why? |
| Endothelial Cells | 2 | 2017 | 2048 | 0.10 | Why? |
| Nasopharynx | 4 | 2022 | 10224 | 0.10 | Why? |
| Mycobacterium bovis | 1 | 2010 | 125 | 0.10 | Why? |
| Double-Blind Method | 2 | 2018 | 5988 | 0.10 | Why? |
| Real-Time Polymerase Chain Reaction | 4 | 2021 | 11367 | 0.09 | Why? |
| Pancreatitis | 1 | 2017 | 688 | 0.09 | Why? |
| Survival Rate | 3 | 2018 | 9206 | 0.09 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.09 | Why? |
| Malaria | 1 | 2019 | 1097 | 0.09 | Why? |
| Kupffer Cells | 2 | 2018 | 34 | 0.09 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.09 | Why? |
| Intestinal Mucosa | 1 | 2016 | 1046 | 0.09 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.09 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.09 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 907 | 0.09 | Why? |
| Radiography | 1 | 2016 | 1576 | 0.09 | Why? |
| Viruses | 1 | 2022 | 2238 | 0.09 | Why? |
| Bacteriological Techniques | 1 | 2010 | 239 | 0.09 | Why? |
| Perioperative Care | 1 | 2019 | 1329 | 0.09 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.09 | Why? |
| Long QT Syndrome | 1 | 2018 | 1047 | 0.09 | Why? |
| Temperature | 1 | 2017 | 2305 | 0.09 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 1458 | 0.08 | Why? |
| Pedigree | 1 | 2008 | 502 | 0.08 | Why? |
| Apoptosis Regulatory Proteins | 2 | 2018 | 202 | 0.08 | Why? |
| Phenotype | 3 | 2018 | 4037 | 0.08 | Why? |
| Premature Birth | 1 | 2019 | 2151 | 0.08 | Why? |
| Colitis, Ulcerative | 1 | 2016 | 1037 | 0.08 | Why? |
| Bronchial Diseases | 1 | 2006 | 31 | 0.08 | Why? |
| Neoplasm Staging | 3 | 2019 | 1999 | 0.08 | Why? |
| Reproducibility of Results | 6 | 2018 | 11304 | 0.08 | Why? |
| Enzyme Inhibitors | 1 | 2017 | 1881 | 0.08 | Why? |
| Esophageal Diseases | 1 | 2006 | 34 | 0.08 | Why? |
| Tumor Burden | 2 | 2018 | 369 | 0.08 | Why? |
| Hypoglycemic Agents | 1 | 2019 | 2165 | 0.08 | Why? |
| Oxygen | 2 | 2017 | 3715 | 0.08 | Why? |
| Aged, 80 and over | 12 | 2021 | 88759 | 0.08 | Why? |
| Monocytes | 1 | 2018 | 2978 | 0.08 | Why? |
| DNA Primers | 1 | 2010 | 1170 | 0.08 | Why? |
| Wounds and Injuries | 1 | 2018 | 1708 | 0.07 | Why? |
| Phosphorylation | 2 | 2019 | 1060 | 0.07 | Why? |
| Polymerase Chain Reaction | 2 | 2010 | 6740 | 0.07 | Why? |
| Signal Transduction | 2 | 2018 | 7207 | 0.07 | Why? |
| Data Interpretation, Statistical | 1 | 2008 | 657 | 0.07 | Why? |
| Stroke | 2 | 2018 | 8839 | 0.07 | Why? |
| Pregnancy Outcome | 1 | 2017 | 3803 | 0.07 | Why? |
| Image-Guided Biopsy | 2 | 2017 | 185 | 0.07 | Why? |
| Host-Pathogen Interactions | 2 | 2021 | 11041 | 0.07 | Why? |
| Biological Products | 1 | 2019 | 2331 | 0.07 | Why? |
| Autoimmune Diseases | 1 | 2017 | 1996 | 0.06 | Why? |
| Colorectal Neoplasms | 1 | 2017 | 1884 | 0.06 | Why? |
| Feces | 1 | 2017 | 4235 | 0.06 | Why? |
| Ultrasonography | 2 | 2017 | 4409 | 0.06 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.06 | Why? |
| Patient Satisfaction | 1 | 2016 | 2517 | 0.06 | Why? |
| Pneumonectomy | 1 | 2006 | 278 | 0.06 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.06 | Why? |
| Phylogeny | 2 | 2021 | 13341 | 0.06 | Why? |
| Aging | 1 | 2019 | 3581 | 0.06 | Why? |
| Cells, Cultured | 3 | 2018 | 5835 | 0.06 | Why? |
| Suppressor Factors, Immunologic | 1 | 2020 | 13 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2019 | 6537 | 0.06 | Why? |
| Coinfection | 1 | 2022 | 6820 | 0.06 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.06 | Why? |
| Communication | 1 | 2019 | 5206 | 0.06 | Why? |
| Mycobacterium tuberculosis | 1 | 2010 | 1164 | 0.05 | Why? |
| Thiocyanates | 1 | 2020 | 28 | 0.05 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2017 | 3051 | 0.05 | Why? |
| Child | 6 | 2019 | 70012 | 0.05 | Why? |
| Rats | 2 | 2018 | 2764 | 0.05 | Why? |
| Brain | 1 | 2017 | 5133 | 0.05 | Why? |
| Students | 1 | 2018 | 5255 | 0.05 | Why? |
| Disease Models, Animal | 4 | 2019 | 10998 | 0.05 | Why? |
| Azepines | 1 | 2019 | 17 | 0.05 | Why? |
| Aminopropionitrile | 1 | 2019 | 3 | 0.05 | Why? |
| Maze Learning | 1 | 2019 | 35 | 0.05 | Why? |
| Darkness | 1 | 2019 | 24 | 0.05 | Why? |
| Severity of Illness Index | 4 | 2020 | 48226 | 0.05 | Why? |
| Nucleotides | 1 | 2022 | 212 | 0.05 | Why? |
| Photic Stimulation | 1 | 2019 | 74 | 0.05 | Why? |
| NF-kappa B | 2 | 2017 | 1301 | 0.05 | Why? |
| Prevalence | 2 | 2022 | 25773 | 0.05 | Why? |
| Flavones | 1 | 2019 | 65 | 0.05 | Why? |
| Photochemical Processes | 1 | 2019 | 75 | 0.05 | Why? |
| History, 21st Century | 2 | 2017 | 1849 | 0.05 | Why? |
| DNA, Protozoan | 1 | 2019 | 77 | 0.05 | Why? |
| Parthenogenesis | 1 | 2018 | 1 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Osteoclasts | 1 | 2019 | 67 | 0.05 | Why? |
| Bacterial Capsules | 1 | 2018 | 39 | 0.05 | Why? |
| Primaquine | 1 | 2019 | 62 | 0.05 | Why? |
| X-Ray Microtomography | 1 | 2018 | 115 | 0.05 | Why? |
| Syndactyly | 1 | 2018 | 3 | 0.05 | Why? |
| Receptors, Cannabinoid | 1 | 2018 | 9 | 0.05 | Why? |
| Spindle Apparatus | 1 | 2017 | 6 | 0.05 | Why? |
| Calcium Channels, L-Type | 1 | 2018 | 15 | 0.05 | Why? |
| Kidney Transplantation | 1 | 2019 | 5397 | 0.05 | Why? |
| Sacrococcygeal Region | 1 | 2018 | 17 | 0.05 | Why? |
| Serotyping | 1 | 2018 | 154 | 0.05 | Why? |
| Organic Anion Transporters | 1 | 2018 | 40 | 0.05 | Why? |
| Ryanodine Receptor Calcium Release Channel | 1 | 2018 | 16 | 0.05 | Why? |
| Neoplasm Invasiveness | 1 | 2021 | 582 | 0.05 | Why? |
| Embryo Culture Techniques | 1 | 2017 | 11 | 0.05 | Why? |
| Fosfomycin | 1 | 2018 | 48 | 0.05 | Why? |
| Twins | 1 | 2019 | 115 | 0.05 | Why? |
| Tibia | 1 | 2018 | 72 | 0.05 | Why? |
| Drug Liberation | 1 | 2018 | 141 | 0.04 | Why? |
| Vascular Patency | 1 | 2018 | 96 | 0.04 | Why? |
| Osteoblasts | 1 | 2018 | 87 | 0.04 | Why? |
| Drosophila melanogaster | 1 | 2018 | 85 | 0.04 | Why? |
| Mice, Inbred ICR | 1 | 2018 | 242 | 0.04 | Why? |
| Play and Playthings | 1 | 2018 | 54 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2019 | 6166 | 0.04 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2018 | 143 | 0.04 | Why? |
| Mice, Nude | 1 | 2019 | 340 | 0.04 | Why? |
| Glycosyltransferases | 1 | 2017 | 12 | 0.04 | Why? |
| Acyltransferases | 1 | 2018 | 61 | 0.04 | Why? |
| Membrane Potential, Mitochondrial | 1 | 2017 | 102 | 0.04 | Why? |
| Endocannabinoids | 1 | 2018 | 56 | 0.04 | Why? |
| Rhodiola | 1 | 2017 | 16 | 0.04 | Why? |
| Administration, Topical | 1 | 2019 | 272 | 0.04 | Why? |
| Embryonic Development | 1 | 2017 | 55 | 0.04 | Why? |
| Minocycline | 1 | 2018 | 101 | 0.04 | Why? |
| Disease Outbreaks | 2 | 2016 | 27595 | 0.04 | Why? |
| Receptors, LDL | 1 | 2017 | 42 | 0.04 | Why? |
| Anastomosis, Surgical | 1 | 2018 | 169 | 0.04 | Why? |
| Biopsy, Large-Core Needle | 1 | 2017 | 81 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2019 | 5440 | 0.04 | Why? |
| Radiology Information Systems | 1 | 2018 | 72 | 0.04 | Why? |
| Neutrophil Activation | 1 | 2020 | 510 | 0.04 | Why? |
| Culture Media, Conditioned | 1 | 2017 | 66 | 0.04 | Why? |
| Genes, Bacterial | 1 | 2018 | 207 | 0.04 | Why? |
| HT29 Cells | 1 | 2016 | 108 | 0.04 | Why? |
| Injections | 1 | 2018 | 237 | 0.04 | Why? |
| Matrix Metalloproteinase 2 | 1 | 2017 | 85 | 0.04 | Why? |
| Anesthetics, Intravenous | 1 | 2017 | 98 | 0.04 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2020 | 669 | 0.04 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 286 | 0.04 | Why? |
| Cyclooxygenase 2 | 1 | 2017 | 129 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2018 | 400 | 0.04 | Why? |
| Infant Mortality | 1 | 2019 | 268 | 0.04 | Why? |
| Rats, Wistar | 1 | 2018 | 621 | 0.04 | Why? |
| Platelet Activation | 1 | 2020 | 660 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Bone and Bones | 1 | 2019 | 235 | 0.04 | Why? |
| Pilot Projects | 2 | 2019 | 5182 | 0.04 | Why? |
| Organ Size | 1 | 2017 | 384 | 0.04 | Why? |
| Benzamides | 1 | 2019 | 421 | 0.04 | Why? |
| Tumor Suppressor Proteins | 1 | 2017 | 165 | 0.04 | Why? |
| Colistin | 1 | 2018 | 217 | 0.04 | Why? |
| Ferrets | 1 | 2021 | 1201 | 0.04 | Why? |
| Guanidines | 1 | 2020 | 499 | 0.04 | Why? |
| Protein Processing, Post-Translational | 1 | 2019 | 634 | 0.04 | Why? |
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 230 | 0.04 | Why? |
| Markov Chains | 1 | 2017 | 502 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2019 | 17020 | 0.04 | Why? |
| Biofilms | 1 | 2018 | 304 | 0.04 | Why? |
| Evaluation Studies as Topic | 1 | 2017 | 391 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Genes, Reporter | 1 | 2017 | 472 | 0.04 | Why? |
| Artifacts | 1 | 2017 | 250 | 0.04 | Why? |
| Liver Failure | 1 | 2018 | 266 | 0.04 | Why? |
| Phenols | 1 | 2017 | 226 | 0.04 | Why? |
| Drug Synergism | 1 | 2018 | 833 | 0.04 | Why? |
| Luciferases | 1 | 2017 | 378 | 0.04 | Why? |
| Mitral Valve | 1 | 2019 | 342 | 0.04 | Why? |
| Rabbits | 1 | 2019 | 1171 | 0.04 | Why? |
| Multidetector Computed Tomography | 1 | 2018 | 307 | 0.04 | Why? |
| Mass Spectrometry | 1 | 2020 | 1165 | 0.04 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.04 | Why? |
| Cell Cycle Proteins | 1 | 2017 | 297 | 0.04 | Why? |
| Cardiomyopathy, Dilated | 1 | 2018 | 251 | 0.04 | Why? |
| Rats, Sprague-Dawley | 1 | 2018 | 987 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2017 | 511 | 0.03 | Why? |
| Tachycardia, Ventricular | 1 | 2018 | 251 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Hypoglycemia | 1 | 2019 | 406 | 0.03 | Why? |
| Adolescent | 7 | 2018 | 86841 | 0.03 | Why? |
| Medical Errors | 1 | 2017 | 201 | 0.03 | Why? |
| Tuberculosis | 1 | 2010 | 2895 | 0.03 | Why? |
| Spleen | 1 | 2018 | 877 | 0.03 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.03 | Why? |
| Fetal Blood | 1 | 2018 | 573 | 0.03 | Why? |
| Hypotension | 1 | 2017 | 392 | 0.03 | Why? |
| Complement Activation | 1 | 2020 | 949 | 0.03 | Why? |
| Bradycardia | 1 | 2017 | 292 | 0.03 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.03 | Why? |
| Infant, Premature | 1 | 2019 | 883 | 0.03 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.03 | Why? |
| Autistic Disorder | 1 | 2018 | 253 | 0.03 | Why? |
| Data Accuracy | 1 | 2019 | 715 | 0.03 | Why? |
| Mesocricetus | 1 | 2019 | 1847 | 0.03 | Why? |
| Probability | 1 | 2017 | 923 | 0.03 | Why? |
| Video Recording | 1 | 2019 | 786 | 0.03 | Why? |
| Antigens, CD | 1 | 2018 | 984 | 0.03 | Why? |
| Open Reading Frames | 1 | 2020 | 1898 | 0.03 | Why? |
| ROC Curve | 2 | 2017 | 6024 | 0.03 | Why? |
| Oxygen Consumption | 1 | 2017 | 711 | 0.03 | Why? |
| Glucose | 1 | 2017 | 573 | 0.03 | Why? |
| Lung Diseases | 1 | 2006 | 2361 | 0.03 | Why? |
| Protein Biosynthesis | 1 | 2017 | 653 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Genetic Variation | 2 | 2018 | 3919 | 0.03 | Why? |
| Troponin T | 1 | 2018 | 771 | 0.03 | Why? |
| Linear Models | 1 | 2019 | 1914 | 0.03 | Why? |
| Life Expectancy | 1 | 2017 | 474 | 0.03 | Why? |
| Radiopharmaceuticals | 1 | 2017 | 763 | 0.03 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.03 | Why? |
| Transcription Factors | 1 | 2018 | 784 | 0.03 | Why? |
| Intestines | 1 | 2018 | 817 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.03 | Why? |
| Biopsy, Needle | 1 | 2013 | 303 | 0.03 | Why? |
| Radiotherapy Dosage | 1 | 2013 | 428 | 0.03 | Why? |
| Donor Selection | 1 | 2018 | 804 | 0.03 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
| Cricetinae | 1 | 2019 | 3344 | 0.03 | Why? |
| Glycated Hemoglobin A | 1 | 2019 | 1316 | 0.03 | Why? |
| Virulence | 1 | 2018 | 2172 | 0.03 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.03 | Why? |
| Taiwan | 1 | 2019 | 2556 | 0.03 | Why? |
| Infant | 3 | 2019 | 30274 | 0.03 | Why? |
| History, 20th Century | 1 | 2017 | 1282 | 0.03 | Why? |
| Neurons | 1 | 2017 | 864 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2018 | 1215 | 0.03 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.03 | Why? |
| Ventricular Dysfunction, Left | 1 | 2019 | 993 | 0.03 | Why? |
| Insulin | 1 | 2019 | 1316 | 0.03 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.03 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.03 | Why? |
| Proteomics | 1 | 2021 | 2481 | 0.02 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.02 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.02 | Why? |
| Ventricular Function, Left | 1 | 2019 | 1555 | 0.02 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.02 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.02 | Why? |
| Child, Preschool | 3 | 2018 | 36283 | 0.02 | Why? |
| Prenatal Care | 1 | 2019 | 1314 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Intracranial Hemorrhages | 1 | 2017 | 1170 | 0.02 | Why? |
| Nucleocapsid Proteins | 1 | 2020 | 3120 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2021 | 3129 | 0.02 | Why? |
| Gastroenterology | 1 | 2018 | 1352 | 0.02 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.02 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.02 | Why? |
| Anesthesia | 1 | 2017 | 1236 | 0.02 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2019 | 3347 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Antimalarials | 1 | 2019 | 2505 | 0.02 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Thoracic Diseases | 1 | 2006 | 118 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2022 | 4239 | 0.02 | Why? |
| Blood Glucose | 1 | 2019 | 3642 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.02 | Why? |
| Chloroquine | 1 | 2019 | 3152 | 0.02 | Why? |
| Fear | 1 | 2019 | 3607 | 0.02 | Why? |
| Electrocardiography | 1 | 2018 | 3957 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.02 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.01 | Why? |
| Time Factors | 2 | 2017 | 31397 | 0.01 | Why? |
| India | 1 | 2019 | 11875 | 0.01 | Why? |
| Registries | 1 | 2021 | 12327 | 0.01 | Why? |
| Time-to-Treatment | 1 | 2017 | 5883 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Genome, Viral | 1 | 2016 | 13157 | 0.01 | Why? |
| Mental Health | 1 | 2017 | 15770 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |